Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 7;39(10):840-849.
doi: 10.1093/eurheartj/ehx721.

Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction

Affiliations

Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction

Viviany R Taqueti et al. Eur Heart J. .

Abstract

Aims: Coronary microvascular ischaemia, cardiomyocyte injury and stiffness may play an important role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). To date, the relationship between coronary flow reserve (CFR), myocardial injury, diastolic dysfunction, and future HFpEF risk is unknown.

Methods and results: Consecutive patients (n = 201) undergoing evaluation for suspected coronary artery disease (CAD) with stress myocardial perfusion positron emission tomography, serum troponin, and transthoracic echocardiography who did not have flow-limiting CAD or reduced left ventricular ejection fraction were identified. Patients were followed up (median 4.1 years) for cardiovascular death and hospitalization for non-fatal myocardial infarction or heart failure. Coronary flow reserve was quantified as stress/rest myocardial blood flow. Early diastolic flow (E) and relaxation (e') velocities were obtained via transmitral and tissue Doppler, respectively. Patients with impaired CFR (<2, n = 108) demonstrated linearly decreasing e' and increasing E/e' consistent with worsening diastolic function (P for trend <0.0001). A detectable troponin was associated with diastolic dysfunction only in the presence of impaired CFR (interaction P = 0.002). In adjusted analyses, impaired CFR was independently associated with diastolic dysfunction (E/e'septal > 15, adjusted OR 2.58, 95%CI 1.22-5.48) and composite cardiovascular outcomes or HFpEF hospitalization alone (adjusted HR 2.47, 95%CI 1.09-5.62). Patients with both impaired CFR and diastolic dysfunction demonstrated >five-fold increased risk of HFpEF hospitalization (P < 0.001).

Conclusion: In symptomatic patients without overt CAD, impaired CFR was independently associated with diastolic dysfunction and adverse events, especially HFpEF hospitalization. The presence of both coronary microvascular and diastolic dysfunctions was associated with a markedly increased risk of HFpEF events.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship between coronary flow reserve (CFR) and markers of diastolic dysfunction. There is a direct relationship between CFR and e′ (A) and an inverse relationship between CFR and E/e′ (B) such that diastolic function sharply declined in patients with CFR < 2. Non-linear relationship is modelled using restricted cubic splines with 95% confidence intervals. Results are shown for eseptal, but similar findings were obtained for elateral.
Figure 2
Figure 2
Univariable and multivariable-adjusted associations for elevated E/e′ (E/eseptal > 15 as compared to ≤ 15). Odds ratios (OR) with 95% confidence intervals (95% CI) are presented for binary covariates, as well as a 10-unit increase in pretest clinical score and age, and a 10-unit decrease in left ventricular ejection fraction. Pretest clinical score incorporates age, gender, presence of hypertension, dyslipidaemia, diabetes, tobacco use, family history of premature CAD, body mass index ≥27 kg/m2, oestrogen status, and anginal history into a risk score for diagnosing significant CAD in a population of symptomatic patients presenting for stress testing: low (0–8), intermediate (9–15), and high (>15).
Figure 3
Figure 3
Adjusted freedom from major adverse cardiovascular events (MACE)*, (A) and hospitalization for heart failure with preserved ejection fraction (HFpEF, (B) by coronary flow reserve (CFR). Event-free survival, adjusted for pretest clinical score, history of atrial fibrillation, estimated glomerular filtration rate <60 mL•min−1•1.73 m−2, detectable troponin, left ventricular ejection fraction and E/eseptal > 15. Freedom from events differed significantly among subgroups stratified by CFR such that patients with low CFR experienced higher rates of composite or HFpEF events (overall P < 0.001 in unadjusted and adjusted analyses).
Figure 4
Figure 4
Freedom from hospitalization for heart failure with preserved ejection fraction (HFpEF) by coronary flow reserve (CFR) and E/eseptal(*). (A) The Kaplan–Meier (unadjusted) analysis of time to first event. (B) Event-free survival, adjusted for pretest clinical score and detectable troponin. (C) Adjusted annualized rates of events. Freedom from HFpEF hospitalization differed significantly among subgroups stratified by CFR and E/e′, such that only those patients with elevated E/e′ and impaired CFR demonstrated the highest risk of hospitalization for HFpEF (P < 0.001).
Take home figure
Take home figure
Conceptual model of the pathophysiology linking coronary microvascular ischaemia, low-level cardiomyocyte injury, and myocardial stiffness to major adverse cardiovascular outcomes (MACE), especially heart failure with preserved ejection fraction (HFpEF). This process may occur even in the absence of obstructive coronary artery or overt structural heart disease. Heart image is adapted from Servier Medical Art. CAD, coronary artery disease.
None

Comment in

References

    1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129–2200. - PubMed
    1. Redfield MM. Heart failure with preserved ejection fraction. N Engl J Med 2016;375:1868–1877. - PubMed
    1. Kelly JP, Mentz RJ, Mebazaa A, Voors AA, Butler J, Roessig L, Fiuzat M, Zannad F, Pitt B, O’Connor CM, Lam CSP.. Patient selection in heart failure with preserved ejection fraction clinical trials. J Am Coll Cardiol 2015;65:1668–1682. - PMC - PubMed
    1. Shah AM, Claggett B, Kitzman D, Biering-Sorensen T, Jensen JS, Cheng S, Matsushita K, Konety S, Folsom AR, Mosley TH, Wright JD, Heiss G, Solomon SD.. Contemporary assessment of left ventricular diastolic function in older adults: the atherosclerosis risk in communities study. Circulation 2017;135:426–439. - PMC - PubMed
    1. Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Røsjø H, Šaltytė Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E; PEACE Investigators. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 2013;61:1240–1249. - PubMed

Publication types